logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Ambalal Sarabhai Enterprises Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    500009
    INE432A01017
    5.880968
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    AMBASARABH
    49.98
    440.49
    EPS(TTM)
    Face Value()
    Div & Yield %:
    1.15
    10
    0
     
Date Headline
13-Nov-2024 Ambalal Sarabhai Enterprises consolidated net profit rises 142.59% in the September 2024 quarter
05-Nov-2024 Ambalal Sarabhai Enterprises to convene board meeting
12-Aug-2024 Ambalal Sarabhai Enterprises Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
09-Aug-2024 Ambalal Sarabhai Enterprises reports consolidated net profit of Rs 0.35 crore in the June 2024 quarter
06-Aug-2024 Ambalal Sarabhai Enterprises Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
06-Aug-2024 Ambalal Sarabhai Enterprises Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
03-Aug-2024 Ambalal Sarabhai Enterprises announces board meeting date
01-Aug-2024 Ambalal Sarabhai Enterprises Ltd - Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended June 30 2024 Along With Limited Review Report Of Auditors Thereon.
23-Jul-2024 Ambalal Sarabhai Enterprises Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
12-Jul-2024 Ambalal Sarabhai Enterprises Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
1 2 3